MedPath

Effects of Transcutaneous Electrical Diaphragmatic Stimulation on Respiratory Variables in COPD Patients

Phase 1
Conditions
COPD
Interventions
Other: TEDS in healthy patients
Other: TEDS in COPD patients
Registration Number
NCT01300442
Lead Sponsor
Universidade Federal de Sao Carlos
Brief Summary

Transcutaneous electrical diaphragmatic stimulation (TEDS) has been used to improve respiratory muscle strength in patients with respiratory muscles weakness. However, this physiotherapeutic resource has not been studied in chronic obstructive pulmonary disease (COPD) yet. The objective of this study is to evaluate the respiratory pattern during the session of TEDS besides its effect in respiratory muscle strength and in spirometric variables as much healthy patients as in COPD patients. Methods: healthy and COPD patients are selected and submitted to TEDS treatment. The plethysmographic analysis (LifeShirt System - VivoMetric), respiratory muscle strength and spirometry will be made. The hypothesis is that the TEDS can helps COPD patients that shows respiratory muscle weakness.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
30
Inclusion Criteria
  • Patients with stable COPD (diagnosed by accepted criteria)
  • Healthy patients
Exclusion Criteria
  • FOR THE COPD PATIENTS:
  • Over 80 years of age
  • History of recent exacerbation
  • Patients with pacemakers
  • Uncontrolled arterial hypertension
  • Requiring home oxygen therapy.
  • FOR THE HEALTHY PATIENTS:
  • Pulmonary diseases
  • Cardiovascular diseases
  • Orthopedic diseases
  • Neurologic diseases.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
ControlTEDS in healthy patientsThe transcutaneous electrical diaphragmatic stimulation will be applied in healthy and COPD subjects.
Chronic Obstructive Pulmonary DiseaseTEDS in COPD patientsThe intervention will be the TEDS in patients with Chronic Obstructive Pulmonary Disease (COPD)
Primary Outcome Measures
NameTimeMethod
Respiratory muscle strength and spirometry06 weeks

Respiratory muscle strength: maximal inspiratory pressure (cH2O) and maximal expiratory pressure (cH2O) by manovacuometer (Gerar®) Spirometry by Spirometer EasyOne®

Secondary Outcome Measures
NameTimeMethod
Respiratory patternDuring the session of transcutaneous electrical diaphragmatic stimulation

Inductance pletismography by LifeShirt® (VivoMetrics). The variables are: inspiratory tidal volume (ViVol); expiratory tidal volume (VeVol); minute ventilation (VE) in liters; inspiratory time (Ti); expiratory time (Te); total breath time (Tt) in seconds; phase relation during inspiration (PhRIB); phase relation during expiration (PhREB); phase relation of the entire breath (PhRTB) and phase angle (PhAng) in percentage (%).

Trial Locations

Locations (1)

UFSCar

🇧🇷

São Carlos, São Paulo, Brazil

© Copyright 2025. All Rights Reserved by MedPath